Verdence Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Buy |
43,846
+63
| +0.1% | +$4.35K | 0.21% | 111 |
|
|
2025
Q1 | $3.04M | Sell |
43,783
-4,684
| -10% | -$325K | 0.23% | 106 |
|
|
2024
Q4 | $4.17M | Buy |
48,467
+5,490
| +13% | +$472K | 0.34% | 69 |
|
|
2024
Q3 | $5.12M | Buy |
42,977
+6,821
| +19% | +$812K | 0.41% | 57 |
|
|
2024
Q2 | $5.16M | Sell |
36,156
-44
| -0.1% | -$6.28K | 0.46% | 51 |
|
|
2024
Q1 | $4.65M | Sell |
36,200
-330
| -0.9% | -$42.4K | 0.42% | 57 |
|
|
2023
Q4 | $3.78M | Buy |
36,530
+3,360
| +10% | +$348K | 0.37% | 65 |
|
|
2023
Q3 | $3.02M | Buy |
33,170
+15,542
| +88% | +$1.41M | 0.33% | 78 |
|
|
2023
Q2 | $1.43M | Buy |
17,628
+9,516
| +117% | +$770K | 0.17% | 154 |
|
|
2023
Q1 | $645K | Buy |
8,112
+1,884
| +30% | +$150K | 0.08% | 263 |
|
|
2022
Q4 | $421K | Buy |
+6,228
| New | +$421K | 0.05% | 308 |
|